Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Why renin inhibitors?

E Haber1

  • 1Squibb Institute for Medical Research, Princeton, New Jersey 08543.

Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|April 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Large-Area Epitaxial Mott Insulating 1T-TaSe<sub>2</sub> Monolayer on GaP(111)B.

Nano letters·2023
Same author

Outcomes of renal replacement therapy in the critically ill with COVID-19.

Medicina intensiva·2021
Same author

Outcomes of renal replacement therapy in the critically ill with COVID-19.

Medicina intensiva·2021
Same author

Use of controlled vignettes in evaluation: does type of response method make a difference?

Evaluation and program planning·2013
Same author

The impact of biotechnology on advances in cardiovascular medicine.

Trends in cardiovascular medicine·2011
Same author

Route of administration-dependent anti-inflammatory effect of liposomal alendronate.

Journal of controlled release : official journal of the Controlled Release Society·2010
Same journal

Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·2009
Same journal

Hypertension and kidney alterations in rat offspring from low protein pregnancies.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·2009
Same journal

Comparison of the effects of indapamide and captopril on the development of spontaneous hypertension.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·2009
Same journal

The protective effect of irbesartan in rats fed a high fat diet is associated with modification of leptin-adiponectin imbalance.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·2009
Same journal

Chronic antioxidant therapy fails to ameliorate hypertension: potential mechanisms behind.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·2009
Same journal

Endothelial dysfunction in spontaneously hypertensive rats: focus on methodological aspects.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·2009
See all related articles

Developing effective renin inhibitors for hypertension and heart failure treatment remains challenging. Current peptide analogue designs show promise but face hurdles in oral bioavailability and clinical advantage over existing therapies.

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine
  • Drug Discovery

Background:

  • Angiotensin converting enzyme (ACE) inhibitors are standard treatments for hypertension and congestive heart failure.
  • Despite their efficacy, research continues for alternative therapies targeting the renin-angiotensin system.
  • Developing orally absorbable renin inhibitors has proven difficult.

Purpose of the Study:

  • To review current strategies and challenges in developing renin inhibitors.
  • To assess the potential of peptide analogues and other approaches in inhibiting renin activity.

Main Methods:

  • Review of existing research on renin inhibitor development.
  • Analysis of peptide analogue design, including the use of statine and modifications for potency and selectivity.

Related Experiment Videos

  • Evaluation of progress in understanding oral bioavailability principles for renin inhibitors.

    • Main Results:

    • Peptide analogues of angiotensinogen, particularly those incorporating statine, are a primary focus for renin inhibitor design.
    • Modifications at the carboxyl terminus can yield potent, smaller renin inhibitors.
    • Peptide analogues of prorenin segments are weak inhibitors with limited therapeutic potential.

    Conclusions:

    • Significant challenges persist in developing orally bioavailable and clinically superior renin inhibitors compared to ACE inhibitors.
    • Further research is needed to overcome bioavailability issues and establish the clinical utility of renin inhibitors.